RRTMX | TBLSX | RRTMX / TBLSX | |
Total Expense Ratio | 1.00 | 0.34 | 294% |
Annual Report Gross Expense Ratio | 1.00 | 0.34 | 294% |
Fund Existence | 18 years | 4 years | - |
Gain YTD | 9.157 | 10.051 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.3B | 142M | 3,732% |
Annual Yield % from dividends | 2.15 | 2.64 | 81% |
Returns for 1 year | 7.69 | 9.74 | 79% |
Returns for 3 years | 15.29 | 34.75 | 44% |
Returns for 5 years | -0.78 | N/A | - |
Returns for 10 years | 11.04 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNEMX | 22.81 | N/A | N/A |
JPMorgan International Equity R6 | |||
HWTIX | 11.92 | -0.03 | -0.25% |
Hotchkis & Wiley Intl Sm Cp Dvsfd Val I | |||
GHAYX | 45.89 | -0.22 | -0.48% |
VanEck Global Resources Fund Y | |||
IVGIX | 18.99 | -0.14 | -0.73% |
VY® Invesco Growth and Income I | |||
FBTIX | 34.21 | -0.56 | -1.61% |
Fidelity Advisor Biotechnology I |